These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 3275487)

  • 1. Tumor markers in pleural effusion diagnosis.
    Tamura S; Nishigaki T; Moriwaki Y; Fujioka H; Nakano T; Fujii J; Yamamoto T; Nabeshima K; Hada T; Higashino K
    Cancer; 1988 Jan; 61(2):298-302. PubMed ID: 3275487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carcinomatous and tuberculous pleural effusions. Comparison of tumor markers.
    Niwa Y; Kishimoto H; Shimokata K
    Chest; 1985 Mar; 87(3):351-5. PubMed ID: 3971760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Diagnostic value of the combined determination of carcinoembryonic antigen (CEA) in pleural effusion and serum with an enzyme immunoassay (EIA). Sensitivity, specificity and relation to tumor type].
    Klech H; Rona G; Hutter C; Bayer PM; Kummer F
    Wien Klin Wochenschr; 1986 Sep; 98(17):564-73. PubMed ID: 3020811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic utility of CYFRA 21-1, carcinoembryonic antigen, CA 125, neuron specific enolase, and squamous cell antigen level determinations in the serum and pleural fluid of patients with pleural effusions.
    Ferrer J; Villarino MA; Encabo G; Felip E; Bermejo B; Vilà S; Orriols R
    Cancer; 1999 Oct; 86(8):1488-95. PubMed ID: 10526277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A clinical study on CEA, TPA, ADA, ferritin, beta 2 microglobulin and sialic acid levels in pleural effusion].
    Reshad K; Suzuki K; Itoi K; Takahashi Y; Hirata T; Yagi T; Sato A; Nakano Y
    Nihon Kyobu Shikkan Gakkai Zasshi; 1987 Nov; 25(11):1174-80. PubMed ID: 3329690
    [No Abstract]   [Full Text] [Related]  

  • 6. Discrimination of tuberculous from carcinomatous pleural effusion by biochemical markers: adenosine deaminase, lysozyme, fibronectin and carcinoembryonic antigen.
    Moriwaki Y; Kohjiro N; Itoh M; Nakatsuji Y; Okada M; Ishihara H; Tachibana I; Kokubu T
    Jpn J Med; 1989; 28(4):478-84. PubMed ID: 2810921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of a panel of tumor markers (carcinoembryonic antigen, cancer antigen 125, carbohydrate antigen 15-3, and cytokeratin 19 fragments) in pleural fluid for the differential diagnosis of benign and malignant effusions.
    Porcel JM; Vives M; Esquerda A; Salud A; Pérez B; Rodríguez-Panadero F
    Chest; 2004 Dec; 126(6):1757-63. PubMed ID: 15596670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor-associated trypsin inhibitor (TATI) in pleural effusions.
    Rapellino M; Pecchio F; Baldi S; Adamo MR; Macri M; Ricardi G
    Scand J Clin Lab Invest Suppl; 1991; 207():47-9. PubMed ID: 1780690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical evaluation of pleural effusion--carcinoembryonic antigen (CEA) and adenosine deaminase (ADA) activities in pleural fluids].
    Yagi S
    Kekkaku; 1990 Dec; 65(12):775-83. PubMed ID: 2077254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic value of soluble receptor-binding cancer antigen expressed on SiSo cells and carcinoembryonic antigen in differentiating malignant from benign pleural effusion.
    Dong J; Sun G; Zhu H
    Tumour Biol; 2016 Mar; 37(3):3257-64. PubMed ID: 26438059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical evaluation of four tumor markers in malignant and benign pleural effusions.
    Toumbis M; Chondros K; Ferderigos AS; Daganou M; Dema A; Dalamaga A; Kakari S; Stringou E
    Anticancer Res; 1992; 12(4):1267-70. PubMed ID: 1503419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Adenosine deaminase activity in tuberculous and malignant pleural effusions].
    Safianowska A; Krenke R; Dmowska-Sobstyl B; Bogacka-Zatorska E; Domagała-Kulawik J; Chazan R
    Pneumonol Alergol Pol; 2006; 74(1):5-9. PubMed ID: 17175968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of pleural CYFRA 21-1 and carcinoembryonic antigen in the diagnosis of malignant pleural effusions.
    Salama G; Miédougé M; Rouzaud P; Mauduyt MA; Pujazon MC; Vincent C; Carles P; Serre G
    Br J Cancer; 1998; 77(3):472-6. PubMed ID: 9472646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic utility of serum and pleural fluid carcinoembryonic antigen, neuron-specific enolase, and cytokeratin 19 fragments in patients with effusions from primary lung cancer.
    Lee JH; Chang JH
    Chest; 2005 Oct; 128(4):2298-303. PubMed ID: 16236887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carcinoembryonic antigen (CEA) levels in pleural effusions and sera of lung cancer patients.
    Ogushi F; Fukuoka M; Takada M; Tamai S; Sakai N; Negoro S; Okunaka N; Sone S; Tsubura E
    Jpn J Clin Oncol; 1984 Sep; 14(3):321-7. PubMed ID: 6090732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical evaluation of various tumor markers in pleural effusion and in the serum].
    Jibiki K; Abe Y; Takeda M; Iwachika C; Odagiri E; Demura R; Demura H
    Gan No Rinsho; 1989 Aug; 35(9):991-8. PubMed ID: 2769951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic value of three tumor markers determined in pleural effusions.
    Conejo JR; Benedito JE; Jimenez A; Menchen M; Cano J; Granizo V; Larrodera L
    Eur J Clin Chem Clin Biochem; 1996 Feb; 34(2):139-42. PubMed ID: 8833646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic value of CA 72-4, carcinoembryonic antigen, CA 15-3, and CA 19-9 assay in pleural fluid. A study of 207 patients.
    Villena V; López-Encuentra A; Echave-Sustaeta J; Martín-Escribano P; Ortuño-de-Solo B; Estenoz-Alfaro J
    Cancer; 1996 Aug; 78(4):736-40. PubMed ID: 8756365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The implication of elevated carcinoembryonic antigen level in pleural fluid of patients with non-malignant pleural effusion.
    Ryu JS; Lee HJ; Cho JH; Han HS; Lee HL
    Respirology; 2003 Dec; 8(4):487-91. PubMed ID: 14629653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential diagnosis of pleural effusions: clinical usefulness of cell marker quantitation.
    Vladutiu AO; Brason FW; Adler RH
    Chest; 1981 Mar; 79(3):297-301. PubMed ID: 6162619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.